Preclinical CRO Industry Assessment: Growth Opportunities and Strategies to 2033
December 11, 2024 07:26 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.This report describes and...
Pharmaceutical CRO Market Report 2025-2030, Featuring Parexel, ICON, Laboratory Corporation of America, Thermo Fisher Scientific, Medpace, IQVIA, WuXi AppTec and Veeda Clinical Research
December 03, 2024 05:20 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules,...
Contract Research Organization (CRO) Services Global Market Report 2024-2029: Increasing Adoption of AI in CROs, Added Efficiency, Inorganic Strategies Fueling Opportunities
November 22, 2024 04:06 ET
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Contract Research Organization (CRO) Services: Global Markets" report has been added to ResearchAndMarkets.com's offering.The contract research...
Patient Derived Xenograft (PDX) Models Market Expects Significant Growth, Reaching $710 Million by 2028 - Global Long-term Forecasts to 2033
November 21, 2024 11:30 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Patient Derived Xenograft (PDX) Models Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The patient derived...
Biosimilars Market Industry Report 2024 - Rising Demand for Biosimilars as a Cost-effective Alternative has Promoted the Need for Increased In-house Development and Outsourcing Operations
November 08, 2024 04:37 ET
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution...
PROTAC Targeted Protein Degraders Market Clinical Trials Insight to 2027 - Emerging PROTAC Therapeutics Set to Revolutionize Targeted Protein Degradation in Clinical Trials
October 23, 2024 12:02 ET
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global PROTAC Targeted Protein Degraders Market Opportunity & Clinical Trials Insight 2027" report has been added to ResearchAndMarkets.com's...
U.S. Preclinical CRO Market Analysis Report 2024-2030: Bioanalysis & DMPK Studies, Toxicology Testing - Life Science Firms Shift Focus to Core Competencies to Boost Efficiency and Innovation
October 04, 2024 05:39 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "U.S. Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By Model Type, By...
CD137 Antibodies Clinical Trials & Market Opportunity - Revolutionary CD137 Antibodies Poised to Transform Cancer Immunotherapy Landscape by 2027
September 12, 2024 04:01 ET
|
Research and Markets
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027" report has been added to ResearchAndMarkets.com's offering. CD137, also...
CD47 Inhibitor Drug Clinical Trials Market Outlook to 2028 - Emerging CD47 Inhibitor Clinical Trials Showcase Potential Cancer Treatment Breakthroughs
September 06, 2024 06:48 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering....
Turkey Cancer Drugs Clinical Trials Market Research 2024 Featuring OMEGA CRO, mediSMART, CRM-CRO, CROTURK, and Klinar CRO
September 05, 2024 04:21 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Turkey Cancer Drugs Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. Turkey presents an expanding...